Effectiveness of inspiratory muscle training in patients with a chronic respiratory disease: an overview of systematic reviews

dc.contributor.authorTorres Castro, Rodrigo
dc.contributor.authorCaicedo Trujillo, Saul
dc.contributor.authorGimeno Santos, Elena, 1980-
dc.contributor.authorGutiérrez Arias, Ruvistay
dc.contributor.authorAlsina Restoy, Xavier
dc.contributor.authorVasconcello Castillo, Laura
dc.contributor.authorSeron, Pamela
dc.contributor.authorSpruit, Martijn A.
dc.contributor.authorBlanco Vich, Isabel
dc.contributor.authorVilaró, Jordi
dc.date.accessioned2025-12-16T15:01:17Z
dc.date.available2025-12-16T15:01:17Z
dc.date.issued2025-05-21
dc.date.updated2025-12-16T15:01:19Z
dc.description.abstractIntroduction: There has been inconclusive findings regarding the effectiveness of inspiratory muscle training (IMT) in chronic respiratory diseases (CRDs). Our objective was to determine the effectiveness of IMT on exercise tolerance, maximum respiratory pressure, lung function, symptoms and quality of life in different CRDs. Methods: We conducted an overview of systematic reviews (SRs) in adults with CRDs who underwent IMT. We reviewed five databases in March 2025. We chose the most comprehensive SRs to report on the analysed outcomes. Results: Twenty-three SRs were included. In chronic obstructive pulmonary disease (COPD), IMT increased the six-minute walk distance (6MWD) by 35.7 m (95% CI 25.7, 45.7), maximum inspiratory pressure (MIP) by 10.9 cmH2O (95% CI 8.0, 13.9). In asthma, IMT increased the forced expiratory volume in the first second (FEV1) by 3.3%pred (95% CI 1.4, 5.1), forced vital capacity (FVC) by 4.1%pred (95% CI 1.0, 7.3), MIP by 21.9 cmH2O (95% CI 15.0, 28.8), and dyspnoea was reduced (standard mean difference -0.8, 95% CI -1.3,-0.2). In obstructive sleep apnoea (OSA), IMT increased MIP by 29.6 cmH2O (95% CI 6.0, 53.1). In pulmonary hypertension (PH), IMT increased 6MWD by 39.0 m (95% CI 20.7, 57.4), MIP in 21.2 cmH2O (95% CI 11.3, 31.1), maximum expiratory pressure by 14.4 cmH2O (95% CI 6.9, 21.9), and dyspnoea was reduced by 0.5 (95% CI 0.1, 0.9) in modified Medical Research Council scale. In lung resection (LR), IMT increased MIP by 8.1 cmH2O (95% CI 1.3, 14.9). In bronchiectasis, IMT increased MIP by 6.1 cmH2O (95% CI 1.4, 10.8). Overall, the most consistent effect of IMT across different CRDs was an increase in MIP. Conclusion: IMT improved several clinically relevant outcomes, including MIP, exercise capacity, and dyspnoea in different CRDs. However, the limited evidence for certain outcomes and populations highlights the need for further high-quality studies.
dc.format.extent13 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec762433
dc.identifier.pmid40469386
dc.identifier.urihttps://hdl.handle.net/2445/224990
dc.language.isoeng
dc.publisherFrontiers Media
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3389/fspor.2025.1549652
dc.relation.ispartofFrontiers in Sports and Active Living, 2025, vol. 7
dc.relation.urihttps://doi.org/10.3389/fspor.2025.1549652
dc.rightscc-by (c) Torres Castro, Rodrigo et al., 2025
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.classificationMúsculs respiratoris
dc.subject.classificationExercicis respiratoris
dc.subject.classificationMalalties de l'aparell respiratori
dc.subject.otherRespiratory muscles
dc.subject.otherBreathing exercises
dc.subject.otherRespiratory diseases
dc.titleEffectiveness of inspiratory muscle training in patients with a chronic respiratory disease: an overview of systematic reviews
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
906750.pdf
Mida:
1.36 MB
Format:
Adobe Portable Document Format